Ruthenium-based catalysts enable hydrogenation of sugars to sugar alcohols by tuning hydrophobicity and electronic states. Using organic ligands and varied support materials, the approach improves catalytic performance and stability, targeting more effective conversion of hydrophilic sugars with non-polar hydrogen and higher selectivity for sugar alcohols while reducing waste.
This solution presents advanced tunable catalysts based on ruthenium (Ru) for the hydrogenation of sugars into sugar alcohols. By optimizing the hydrophobicity and electronic state of Ru catalysts through the use of organic ligands and varied support materials, these catalysts offer enhanced performance and stability. The innovation addresses the challenge of converting hydrophilic sugars with non-polar hydrogen, supporting more effective reactions and higher selectivity for sugar alcohols while minimizing waste.
Key features of this catalyst technology include:
The catalysts are synthesized with controlled support materials that create oxygen vacancies, serving as additional adsorption sites, and provide enhanced stability against leaching through bound organic ligands.
This technology is at Technology Readiness Level 5, indicating that the catalysts have been validated in a relevant environment. The next steps involve further testing of synthesized catalysts, correlation of structure with performance metrics, and scale-up for industrial deployment.
The University of Utah is a comprehensive public research university in Salt Lake City, paired with the resources of a major academic medical center. Industry partners engage through an on-campus research and technology park that co-locates companies with faculty labs and shared core facilities. Clinical integration supports large-scale trials and translation, while proximity to Silicon Slopes expands access to regional innovation partners. Research is supported by competitive federal funding from NIH and NSF, with additional awards from DOE and the Department of Defense. A dedicated technology commercialization office manages IP, licensing, startup formation, and corporate engagement, with incubator space in the research park.